Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Sorrento Therapeutics Remains a Buy Between $6 and $6.50

By Will Ashworth, InvestorPlace Contributor

Sorrento Therapeutics has seen SRNE stock close between $5.76 and $8.20 in the past month. Here’s why it’s time for investors to be careful. 

What Will the Next 9 Years Be Like for Nokia Stock?

By Will Ashworth, InvestorPlace Contributor

If you invested $1,000 in Nokia in September 2011, you’d have $1,000 today. So, what will the next nine years be like for NOK stock? 

It’s Crazy That Palantir Stock Is On Track for Annual Gains of 1,386%

By Will Ashworth, InvestorPlace Contributor

Palantir stock went public in September. Up 231% from its reference price of $7,25, what are the odds it gains 1,386% by Sep. 30, 2021? 

Wells Fargo Is Up 22% Over the Past Month. Who’s Buying?

By Will Ashworth, InvestorPlace Contributor

Warren Buffett’s been selling a lot of Wells Fargo in recent quarters. Who's buying WFC stock to push it 22% higher in the past month?

Vaccines Won’t Stop Shopify’s Future Growth 

By Will Ashworth, InvestorPlace Contributor

While vaccines ought to slow e-commerce growth, it shouldn’t dim the prospects for companies like Shopify and SHOP stock. Here’s why. 

Load More